Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 3,253 | 2,409 | 4,338 | 3,200 | 5,629 |
| Operating Income | -3,253 | -2,409 | -4,338 | -3,200 | -5,629 |
| Interest Expense | 2 | 4 | 6 | 3 | 2 |
| Other Income | 37 | 39 | 43 | 26 | 25 |
| Pre-tax Income | -3,219 | -2,375 | -4,301 | -3,176 | -5,606 |
| Net Income Continuous | -3,219 | -2,375 | -4,301 | -3,176 | -5,606 |
| Net Income | $-3,219 | $-2,375 | $-4,301 | $-3,176 | $-5,606 |
| EPS Basic Total Ops | -5.76 | -6.42 | -18.97 | 15,986.43 | -153.20 |
| EPS Basic Continuous Ops | -5.76 | -6.42 | -18.94 | 16,400.01 | -151.51 |
| EPS Diluted Total Ops | -5.76 | -6.42 | -18.97 | 15,986.43 | -153.20 |
| EPS Diluted Continuous Ops | -5.76 | -6.42 | -18.94 | 16,400.01 | -151.51 |
| EPS Diluted Before Non-Recurring Items | -5.76 | -6.42 | -18.97 | N/A | -150.06 |
| EBITDA(a) | $-3,253 | $-2,408 | $-4,337 | $-3,199 | $-5,628 |